» Articles » PMID: 30250583

A Novel Frameshift Mutation Identified in a Family with Multiple Osteochondromas

Overview
Journal Oncol Lett
Specialty Oncology
Date 2018 Sep 26
PMID 30250583
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Multiple osteochondromas (MO) is an autosomal inherited disease that is characterized by benign bone tumors. However, the underlying mechanism of MO at a molecular level requires further investigation. The majority of mutations associated with MO occur in the exostosin glycosyltransferase genes ( or . In the present study, the genetic causes of the disease were investigated. Polymerase chain reaction amplification, followed by DNA sequencing of the complete and coding regions, were conducted in a family with MO (n=5). A novel frameshift mutation in exon 3 of (c.660delG) was detected. The production of a defective EXT2 protein, lacking 450 C-terminal amino acid residues is predicted to be caused by the c.660delG mutation, located within the exostosin domain of . The missing residues contain the exostosin and glycosyltransferase family 64 domains, which are critical for the function of EXT2. The novel c.660delG frameshift mutation in the gene extends the etiological understanding of MO and may provide an effective reference for genetic counseling and prenatal diagnosis in this family.

Citing Articles

Exostosin1 as a novel prognostic and predictive biomarker for squamous cell lung carcinoma: A study based on bioinformatics analysis.

Wu D, Huo C, Jiang S, Huang Y, Fang X, Liu J Cancer Med. 2020; 10(8):2787-2801.

PMID: 33314711 PMC: 8026939. DOI: 10.1002/cam4.3643.

References
1.
Anower-E-Khuda M, Matsumoto K, Habuchi H, Morita H, Yokochi T, Shimizu K . Glycosaminoglycans in the blood of hereditary multiple exostoses patients: Half reduction of heparan sulfate to chondroitin sulfate ratio and the possible diagnostic application. Glycobiology. 2013; 23(7):865-76. DOI: 10.1093/glycob/cwt024. View

2.
Williams K, Fuki I . Cell-surface heparan sulfate proteoglycans: dynamic molecules mediating ligand catabolism. Curr Opin Lipidol. 1997; 8(5):253-62. DOI: 10.1097/00041433-199710000-00003. View

3.
Esko J, Selleck S . Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem. 2002; 71:435-71. DOI: 10.1146/annurev.biochem.71.110601.135458. View

4.
Tumova S, Woods A, Couchman J . Heparan sulfate proteoglycans on the cell surface: versatile coordinators of cellular functions. Int J Biochem Cell Biol. 2000; 32(3):269-88. DOI: 10.1016/s1357-2725(99)00116-8. View

5.
Xu L, Xia J, Jiang H, Zhou J, Li H, Wang D . Mutation analysis of hereditary multiple exostoses in the Chinese. Hum Genet. 1999; 105(1-2):45-50. DOI: 10.1007/s004399900058. View